Status:
COMPLETED
Additive Effect of Ezetimibe Upon Simvastatin During Myocardial Infarction
Lead Sponsor:
Brasilia Heart Study Group
Conditions:
Myocardial Infarction
Eligibility:
All Genders
40-70 years
Phase:
PHASE4
Brief Summary
During acute coronary syndromes (ACS), the generation of inflammatory mediators negatively influences arterial wall remodeling and the endothelium-dependent vasomotor function in the coronary and syst...
Eligibility Criteria
Inclusion
- less than 24 hours after the onset of myocardial infarction symptoms
- ST-segment elevation of a least 1 mm (frontal plane) or 2 mm (horizontal plane) in two contiguous leads
- myocardial necrosis, as evidenced by increased CK-MB and troponin levels
Exclusion
- use of statins for the last 6 months before myocardial infarction
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00905905
Start Date
May 1 2009
End Date
January 1 2010
Last Update
March 24 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Base do Distrito Federal
Brasília, Federal District, Brazil, 70673103